Trials / Unknown
UnknownNCT02240524
Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric Cancer
A Phase III Study of Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2 Lymphadenectomy
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 582 (estimated)
- Sponsor
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to study the efficacy of hyperthermic intraperitoneal chemotherapy in the treatment of patients with locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy. It is a multicentric and randomised phase III trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | D2 lymphadenectomy | The dissected lymph nodes were classified according to the Japanese Classification of Gastric Carcinoma, first English edition. |
| PROCEDURE | Systemic chemotherapy | |
| PROCEDURE | HIPEC |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2019-07-01
- Completion
- 2019-07-01
- First posted
- 2014-09-15
- Last updated
- 2014-09-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02240524. Inclusion in this directory is not an endorsement.